The drive to Bristol took three hours through countryside that would have been picturesque under different circumstances. Rolling hills, patchwork fields, the occasional spire of a village church piercing the grey sky. But Blackwood saw none of it. His mind was elsewhere, turning over the pieces of the case like a man sifting through broken glass, searching for the one shard that would cut through the legal armor Aegis had constructed.
Lin drove while Blackwood reviewed the dossier on Dr. Isaac Poole. The man was fifty-seven years old, a biochemist of considerable reputation. Before Aegis, he had spent fifteen years at the Wentworth Institute, a government-funded research facility that had produced some of the most important neurological discoveries of the past quarter-century. He had been recruited by Aegis with promises of unlimited research funding and the opportunity to develop treatments that would transform the lives of millions. Instead, he had found himself entangled in what he later described, in his whistleblower complaint, as "a systematic effort to conceal data that could jeopardize regulatory approval."
The complaint itself was a masterpiece of bureaucratic understatement. Poole had documented seventeen instances where adverse event data had been altered or omitted from reports submitted to the Federal Drug Administration. Seventeen instances. And those were just the ones he had been able to prove.
"Why did the FDA dismiss his complaint?" Blackwood asked, not looking up from the papers.
"Officially, insufficient evidence. Unofficially, the investigator assigned to the case was a former colleague of Sterling's from their time at the Wentworth Institute. There's a revolving door between the regulatory agencies and the pharmaceutical industry. People move back and forth, and loyalties get blurred."
"Conflict of interest."
"Rampant. But it's legal. The regulations governing these agencies are riddled with loopholes. Poole's complaint was reviewed by someone who owed his career to the same network of scientists and executives that runs Aegis. The outcome was never in doubt."
They arrived in Bristol just after ten o'clock, the city's streets slick with rain. Dr. Poole's consulting office was located in a converted warehouse in the Harbourside district, a gentrified area of exposed brick and artisanal coffee shops. The address led them to a nondescript door wedged between a vegan bakery and a co-working space, a brass plaque beside it reading "Poole Biosciences Consulting" in discreet lettering.
Poole met them at the door himself. He was a slight man, balding and bespectacled, with the stooped shoulders of someone who had spent decades hunched over microscopes and laboratory benches. His handshake was tentative, his eyes darting past them to the street beyond, as if he expected someone to be watching.
"Come in, come in. Quickly, please." He ushered them inside and locked the door behind them, sliding a deadbolt into place. "I apologize for the cloak-and-dagger routine. Old habits."
The office was small and cluttered, stacked with journals and filing boxes. A whiteboard on one wall was covered in chemical formulas and metabolic pathways, the markers faded from repeated erasure. Poole cleared a stack of papers from two chairs and gestured for them to sit.
"I wasn't sure I should agree to this meeting," he said, settling behind his desk. "My settlement agreement with Aegis is very specific. I'm not permitted to discuss anything related to my work there. If they find out I've spoken with you, they could sue me for everything I have."
"We understand the risk, Dr. Poole," Blackwood said. "And we wouldn't ask if it weren't important. People are dying. The Revivex trial at Seaview Rest Home has killed at least eight people, and five more are in hospital. We believe the deaths were caused by a compound deliberately added to the medication."
Poole's face went pale. "A compound? What kind of compound?"
"A synthetic coagulant. It causes microembolisms and cardiac arrest. It clears from the bloodstream within hours of death, making it virtually undetectable in standard autopsies."
"Thromboxane-C," Poole whispered. "He actually did it."
"Who did what?"
Poole stood up and walked to the whiteboard, his hands trembling slightly. "Thromboxane-C was a compound I developed during my early years at Aegis. It was intended to be a rapid-acting clotting agent for use in battlefield medicine. The idea was that a single injection could stop internal bleeding within minutes, saving soldiers' lives before they could be evacuated to a field hospital. But during testing, we discovered a serious problem. The compound didn't just promote clotting at the wound site. It triggered systemic coagulation, forming microembolisms throughout the body. Tiny clots that would lodge in the brain, the heart, the lungs. The effects were cumulative and, eventually, fatal."
"And this compound was abandoned?"
"Officially, yes. The project was shut down, the research archived. But Victor Sterling was fascinated by it. He saw potential applications that the rest of us found... troubling. He argued that a compound capable of causing undetectable cardiac events could have uses in covert operations. A poison that left no trace. I thought he was speaking theoretically. I should have realized he was deadly serious."
Lin leaned forward. "Dr. Poole, are you saying that Sterling deliberately used your research to create a weapon?"
"I'm saying that Sterling has always been more interested in the applications of science than in its ethics. At Northwick, he pushed through a clinical trial for Cerebra even after we discovered it could interact fatally with common blood pressure medications. Four people died, and Sterling walked away without a mark on his record. He learned a lesson from that experience, I think. Not that killing patients was wrong, but that getting caught was inconvenient. He needed a method that would leave no evidence behind."
"Thromboxane-C."
"Combined with Revivex, or something similar. A cognitive enhancer would be the perfect delivery system. Elderly patients with pre-existing heart conditions. Deaths attributed to natural causes. No autopsies, no toxicology screens, no questions asked." Poole sat down heavily, his face grey. "How many did you say have died?"
"Eight that we know of. Possibly more."
"God help us." Poole removed his glasses and rubbed his eyes. "I should have spoken out years ago. When I saw what was happening at Northwick, I should have gone to the press, to the police, to anyone who would listen. But I was afraid. Sterling has connections everywhere. He made it clear that anyone who crossed him would never work in this industry again."
"It's not too late, Dr. Poole. You can still testify. We're building a federal fraud case. If we can prove that Aegis deliberately falsified data and concealed adverse events from the regulatory authorities, we can bring charges that no amount of jurisdictional maneuvering can dismiss."
"Testify?" Poole laughed, a bitter, hollow sound. "You don't understand. My settlement agreement doesn't just prohibit me from discussing Aegis. It requires me to notify them immediately if I am contacted by any law enforcement agency. If I fail to do so, I forfeit my settlement—every penny—and open myself to additional penalties. They designed the agreement to make cooperation with investigators financially ruinous."
"When did you receive it?" Lin asked.
"The agreement? Eighteen months ago, when I was terminated."
"No, I mean the notification from Aegis. Telling you to expect our visit."
Poole stared at her. "I don't know what you're talking about."
Blackwood and Lin exchanged a glance. "Dr. Poole," Blackwood said carefully, "someone has been watching us. We believe Aegis has been monitoring our investigation from the beginning. If they knew we were coming to see you, they may have already taken steps to discredit your testimony or worse."
"But... how would they know? I haven't told anyone. I haven't spoken to anyone from Aegis in over a year."
"Your phone. Your email. Your office. If Sterling is as connected as you say, he could have any of them monitored." Blackwood stood up. "We need to move. If you're willing to testify, we can place you in protective custody immediately. Federal witness protection, if necessary. But you need to decide now, before Sterling's people have a chance to act."
Poole hesitated, his eyes moving between them. Blackwood could see the fear in his face, the years of intimidation and threats, the career that had been destroyed by a single act of conscience. But he could also see something else: a flicker of the same defiance that had led Poole to file his whistleblower complaint in the first place.
"I have copies," Poole said quietly. "Of everything. The original data from the Northwick trial. The adverse event reports for Revivex. Internal memos where Sterling discusses the need to 'manage' unfavorable results. I kept backups of everything before I left. They think they silenced me, but I've been waiting. Waiting for someone to ask the right questions."
"Where are the copies?"
"Not here. I keep them in a safety deposit box at a bank in Cardiff. The key is—"
A sound from the street made him stop. Footsteps. Multiple sets of footsteps, approaching the door. Blackwood moved to the window and peered through the blinds. Two men in dark suits were standing outside, examining the brass plaque beside the door. One of them was the man from the hospital.
"They're here," Blackwood said. "Is there another way out?"
Poole was already on his feet, his earlier fear replaced by a focused urgency. "The back. Through the stockroom. There's an alley that leads to the waterfront."
"Get the key to the safety deposit box. Take nothing else. We'll contact you when it's safe."
"But my research, my notes—"
"Will be worthless if you're dead. Go. Now."
Poole grabbed a coat from the back of his chair and a small leather satchel from a drawer. He led them through a door at the rear of the office, into a cramped stockroom filled with boxes of laboratory supplies, and through another door that opened onto a narrow alley. The smell of the harbor was strong here, salt and diesel and rotting wood.
"Cardiff," Poole said, pressing a small brass key into Blackwood's hand. "Crown Mercantile Bank, vault 734. The access code is my mother's maiden name, reversed: Notlimah. But without me, you won't be able to open the box. The bank requires biometric verification."
"Then we'll find a way to get you there safely. For now, find somewhere to hide. A hotel, a friend's house. Pay in cash. Don't use your credit cards or your phone. We'll be in touch."
Poole nodded and disappeared down the alley, his slight figure swallowed by the mist that was rolling in from the harbor. Blackwood and Lin waited in the stockroom, listening as the men in dark suits tried the front door, found it locked, and eventually walked away.
"They'll be back," Lin said. "With a warrant, or a locksmith, or both."
"Then we need to be gone before they return." Blackwood tucked the safety deposit key into his coat pocket. "Cardiff. Crown Mercantile Bank. If Poole's documents are what he claims they are, we have everything we need to bring Aegis down."
"And if they're not?"
"Then we have nothing, and Sterling wins."
They slipped out of the stockroom and made their way through the alley to the waterfront, blending into the midmorning crowd of tourists and office workers. As they walked, Blackwood's mind was already racing ahead, planning the next steps. They needed to get Poole into protective custody. They needed to retrieve the documents from the bank in Cardiff. They needed to brief Agent Mallory and convince the federal authorities to take the case. And they needed to do all of it before Sterling's lawyers shut them down completely.
"Do you think Poole will be safe?" Lin asked.
"I don't know. But he's been living with this secret for years. He knows how to hide."
They reached the car and drove out of Bristol, the city receding in the rearview mirror. Behind them, Blackwood knew, the men in dark suits would be searching the office, cataloguing what Poole had left behind, reporting back to Sterling that their quarry had slipped away.
The chase was on now, and the stakes could not be higher.
Back in Eastport, they found a message waiting from Dr. Marsh. The coroner had completed her review of the death certificates she had signed for Seaview residents over the past two years. Eighteen deaths in total, all attributed to heart failure or stroke. All of them participants in one Aegis clinical trial or another. The pattern was clear, and it stretched back far longer than Blackwood had initially suspected.
"Eighteen," Lin said, her voice flat. "He's been doing this for two years. Maybe longer."
"And we only found out because of a crossword puzzle." Blackwood sat down at his desk, suddenly feeling every one of his sixty-three years. "If Arthur hadn't left that message, if I hadn't been his next of kin, if I hadn't been stubborn enough to push when everyone told me to let it go... Sterling would still be out there. Still killing. Still signing death certificates with a clear conscience."
"But you did push. And we are going to stop him."
Blackwood looked at her. "Yes. We are."
That night, he called Agent Mallory. The conversation lasted nearly an hour, Blackwood laying out the evidence they had gathered, the witnesses they had identified, the legal strategy they were proposing. Mallory listened in silence, asking occasional questions in her clipped, precise voice. When he finished, there was a long pause.
"You've done impressive work, Inspector," she said finally. "And I agree that the federal fraud angle is viable. But I need to be honest with you. A case like this, against a company like Aegis, requires resources. Manpower. Political will. I can't promise any of that without seeing the documents Dr. Poole has stored in Cardiff."
"Then we'll get the documents."
"And the witness? Mrs. Fairchild? She's still willing to testify?"
"She is. Though her health is fragile."
"Then we need to move quickly. I'll start the paperwork for a federal investigation. Meet me in Cardiff tomorrow. Bring everything you have."
Blackwood hung up and sat in the darkness, the weight of the case settling around him. Tomorrow, they would drive to Cardiff. Tomorrow, they would open the safety deposit box and see what secrets Isaac Poole had preserved. Tomorrow, they would begin the final phase of the investigation.
But tonight, there was only the darkness and the waiting, and the crossword puzzle on the table, its grid now almost completely filled. Only one clue remained blank, a seven-letter word running diagonally from the top right to the bottom left.
Blackwood picked up his pen and wrote, in careful, deliberate letters: J U S T I C E.
The puzzle was complete. The message was clear. All that remained was to deliver it.
No comments yet. Be the first to comment!